Literature DB >> 24832730

Freezing-induced perturbation of tertiary structure of a monoclonal antibody.

Lu Liu1, Latoya Jones Braun1, Wei Wang2, Theodore W Randolph3, John F Carpenter4.   

Abstract

We studied the effects of pH and solution additives on freezing-induced perturbations in the tertiary structure of a monoclonal antibody (mAb) by intrinsic tryptophan fluorescence spectroscopy. In general, freezing caused perturbations in the tertiary structure of the mAb, which were reversible or irreversible depending on the pH or excipients present in the formulation. Protein aggregation occurred in freeze-thawed samples in which perturbations of the tertiary structure were observed, but the levels of protein aggregates formed were not proportional to the degree of structural perturbation. Protein aggregation also occurred in freeze-thawed samples without obvious structural perturbations, most likely because of freeze concentration of protein and salts, and thus reduced protein colloidal stability. Therefore, freezing-induced protein aggregation may or may not first involve the perturbation of its native structure, followed by the assembly processes to form aggregates. Depending on the solution conditions, either step can be rate limiting. Finally, this study demonstrates the potential of fluorescence spectroscopy as a valuable tool for screening therapeutic protein formulations subjected to freeze-thaw stress.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  excipients; formulation; liquid chromatography; monoclonal antibody; protein aggregation; proteins; stability; surfactants

Mesh:

Substances:

Year:  2014        PMID: 24832730      PMCID: PMC4069245          DOI: 10.1002/jps.24013

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  32 in total

1.  Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins.

Authors:  S C Rumsey; N F Galeano; Y Arad; R J Deckelbaum
Journal:  J Lipid Res       Date:  1992-10       Impact factor: 5.922

2.  Monoclonal antibody successes in the clinic.

Authors:  Janice M Reichert; Clark J Rosensweig; Laura B Faden; Matthew C Dewitz
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

3.  Protein stability in ice.

Authors:  Giovanni B Strambini; Margherita Gonnelli
Journal:  Biophys J       Date:  2006-12-22       Impact factor: 4.033

Review 4.  Effects of protein aggregates: an immunologic perspective.

Authors:  Amy S Rosenberg
Journal:  AAPS J       Date:  2006-08-04       Impact factor: 4.009

5.  Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor.

Authors:  Renuka Thirumangalathu; Sampathkumar Krishnan; David N Brems; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2006-07       Impact factor: 3.534

Review 6.  Phase separation of excipients during lyophilization: effects on protein stability.

Authors:  T W Randolph
Journal:  J Pharm Sci       Date:  1997-11       Impact factor: 3.534

7.  Proteins in frozen solutions: evidence of ice-induced partial unfolding.

Authors:  G B Strambini; E Gabellieri
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

8.  Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII.

Authors:  L Kreilgaard; L S Jones; T W Randolph; S Frokjaer; J M Flink; M C Manning; J F Carpenter
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

9.  Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin.

Authors:  B A Kerwin; M C Heller; S H Levin; T W Randolph
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

10.  Singular efficacy of trimethylamine N-oxide to counter protein destabilization in ice.

Authors:  Giovanni B Strambini; Margherita Gonnelli
Journal:  Biochemistry       Date:  2008-02-23       Impact factor: 3.162

View more
  11 in total

1.  Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs.

Authors:  Friederike Plath; Philippe Ringler; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Melissa A Graewert; Dmitri Svergun; Gerald Gellermann; Christof Finkler; Jan O Stracke; Atanas Koulov; Volker Schnaible
Journal:  MAbs       Date:  2016-03-31       Impact factor: 5.857

2.  Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.

Authors:  Srivalli Telikepalli; Heather E Shinogle; Prem S Thapa; Jae Hyun Kim; Meghana Deshpande; Vibha Jawa; C Russell Middaugh; Linda O Narhi; Marisa K Joubert; David B Volkin
Journal:  J Pharm Sci       Date:  2015-03-05       Impact factor: 3.534

Review 3.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

4.  Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo.

Authors:  Claire L Dobson; Paul W A Devine; Jonathan J Phillips; Daniel R Higazi; Christopher Lloyd; Bojana Popovic; Joanne Arnold; Andrew Buchanan; Arthur Lewis; Joanne Goodman; Christopher F van der Walle; Peter Thornton; Lisa Vinall; David Lowne; Anna Aagaard; Lise-Lotte Olsson; Anna Ridderstad Wollberg; Fraser Welsh; Theodoros K Karamanos; Clare L Pashley; Matthew G Iadanza; Neil A Ranson; Alison E Ashcroft; Alistair D Kippen; Tristan J Vaughan; Sheena E Radford; David C Lowe
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

Review 5.  Molecular and functional analysis of monoclonal antibodies in support of biologics development.

Authors:  Xin Wang; Zhiqiang An; Wenxin Luo; Ningshao Xia; Qinjian Zhao
Journal:  Protein Cell       Date:  2017-07-21       Impact factor: 14.870

6.  The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors.

Authors:  N D Vlieland; M R Nejadnik; H Gardarsdottir; S Romeijn; A S Sediq; M L Bouvy; A C G Egberts; B J F van den Bemt; W Jiskoot
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

7.  Protein freeze concentration and micro-segregation analysed in a temperature-controlled freeze container.

Authors:  Ulrich Roessl; Stefan Leitgeb; Bernd Nidetzky
Journal:  Biotechnol Rep (Amst)       Date:  2015-03-26

8.  Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine.

Authors:  Sanjeev Agarwal; Neha Sahni; John M Hickey; George A Robertson; Robert Sitrin; Stanley Cryz; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-08-07       Impact factor: 3.534

9.  Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.

Authors:  Astrid Hauptmann; Katja Podgoršek; Drago Kuzman; Stanko Srčič; Georg Hoelzl; Thomas Loerting
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

10.  Investigation of the reversibility of freeze/thaw stress-induced protein instability using heat cycling as a function of different cryoprotectants.

Authors:  Anna K Wöll; Jürgen Hubbuch
Journal:  Bioprocess Biosyst Eng       Date:  2020-03-20       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.